This is based on the findings that PTX3 serum levels are significantly increased in patients with aCD compared with patients in remission, its expression is higher in inflamed colonic tissues compared with uninflamed colonic tissues, and its serum levels positively correlate with disease activity in CD. The gene discussed is PTX3; the disease is granular corneal dystrophy type II.